HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ainhoa Ruiz Del Agua Selected Research

Adalimumab (Humira)

9/2021Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ainhoa Ruiz Del Agua Research Topics

Disease

2Rheumatic Diseases (Rheumatism)
09/2021 - 01/2016
2Rheumatoid Arthritis
09/2021 - 08/2011
1Psoriatic Arthritis
09/2021
1Ankylosing Spondylitis
09/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019
1Axial Spondyloarthritis
01/2018

Drug/Important Bio-Agent (IBA)

2Infliximab (Remicade)FDA Link
01/2016 - 08/2011
1Adalimumab (Humira)FDA Link
09/2021
1Ustekinumab (CNTO 1275)FDA Link
01/2019
1golimumabFDA Link
01/2018

Therapy/Procedure

2Therapeutics
09/2021 - 01/2018